Centre Régional en Antibiothérapie du Grand Est - AntibioEst

Name

Centre Régional en Antibiothérapie du Grand Est - AntibioEst

Legal name

Centre Régional en Antibiothérapie du Grand Est – AntibioEst

Website

https://antibioest.org

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Public Health Services

NAICS

Offices of Physicians (6211), Medical and Diagnostic Laboratories (6215)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Antimicrobial Stewardship (HLAKAGAG)

akta.pro secondary industries

Healthcare-Associated Infection (HAI) & Antimicrobial Resistance (AMR) Surveillance (HLAJABAH), Antimicrobial Resistance (AMR) & Antibiotic Susceptibility Reference Networks (HLAJAIAF)

Keywords

• Antibiotic stewardship services
• Public health coordination
• Clinical decision support
• Antimicrobial resistance surveillance
• Healthcare professional training

Headquarters

HQ city

Nancy

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Public Health Funding: AntibioEst is a publicly-funded regional healthcare coordination center operating under the authority of the Agence Régionale de Santé (ARS) Grand Est. The organization does not generate commercial revenue but operates through government health authority funding and institutional support.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

AntibioEst is a public regional healthcare coordination center that promotes proper antibiotic use and combats antibiotic resistance across the Grand Est region of France. It provides healthcare professionals with evidence-based antibiotic prescribing guidance through mobile applications (Antibioguide, Antibiodentaire, Antibioclic), monthly newsletters, clinical documentation, infectious disease consultations, continuing education programs, and surveillance of antibiotic resistance in healthcare settings under the SPARES national mission.

Product overview

AntibioEst is a regional healthcare organization providing antibiotic stewardship resources and guidance for healthcare professionals. The organization offers three primary digital products: Antibioguide (a general antibiotic prescribing guide available as a mobile app), Antibiodentaire (a dental-specific antibiotic guide), and Antibioclic (an online antibiotic prescribing decision-support tool). These tools are complemented by newsletters, webinars, training programs, clinical recommendations, and documentation resources covering various healthcare settings including hospitals, EHPADs (nursing homes), primary care, and dental care.

Differentiator

Problem solved

Functional benefit

Brands

• AntibioGuide: Antibiotic prescription guide application
• AntibioDentaire
• AntibioClic

Products and services

• Antibioguide A comprehensive antibiotic prescribing guide available as a mobile application for Android and iOS devices, providing healthcare professionals with guidance on antibiotic selection and dosing.
• Antibiodentaire A specialized antibiotic guide for dental care practitioners, providing recommendations for antibiotic prescribing in dental procedures and infections.
• Antibioclic An online antibiotic prescribing decision-support tool that assists healthcare professionals in selecting appropriate antibiotic treatments.

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Agence Régionale de Santé Grand Est (ARS GE)coreStrategic or Co-development PartnerAntibioEst operates under the authority of ARS Grand Est as the designated Centre Régional en Antibiothérapie (CRAtb) for the region. The organization fulfills its mission to promote proper antibiotic use and combat antibiotic resistance under the oversight and mandate of the regional health authority.
• SPARES (Surveillance et Prévention de l'Antibiorésistance en Établissements de Santé)coreStrategic or Co-development PartnerNational mission for surveillance and prevention of antibiotic resistance in healthcare settings, coordinated at regional level through CRAtb AntibioEst.
• EMA Grand Est (Équipes Multidisciplinaires en Antibiothérapie)coreStrategic or Co-development PartnerCoordination of Multidisciplinary Antibiotic Therapy Teams across healthcare facilities in the Grand Est region.
• RePIAminorStrategic or Co-development PartnerNetwork for surveillance and prevention of antibiotic resistance; joint activities on blood exposure accidents (AES) in medical-social establishments.
• CPIAS (Centres d'Appui pour la Prévention des Infections Associées aux Soins)coreStrategic or Co-development PartnerNational directory collaboration with CPIAS networks for infection prevention support across healthcare regions.
• Ministère de la Santé (Ministry of Health)coreOthersOperates under national strategy 2022-2025 for infection prevention and antibiotic resistance, following ministerial instruction of May 15, 2020 and Decree n°2022-1445 of November 18, 2022.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• SPILF (Société de Pathologie Infectieuse de Langue Française): The national French infectious disease society that produces clinical guidelines AntibioEst operationalizes at the regional level. AntibioEst leadership participates in SPILF seminars (RICAI), making it both an upstream authority and a peer in the antibiotic stewardship ecosystem.
• ECDC (European Centre for Disease Prevention and Control) — Antimicrobial Resistance: EU-level agency coordinating AMR surveillance (EARS-Net) and stewardship policy. Functionally analogous to AntibioEst's surveillance and coordination role but operating across all EU member states, providing the supranational framework within which CRAtbs like AntibioEst operate.
• Public Health England / UK Health Security Agency — AMR Programme: National-level AMR surveillance and stewardship coordination body in the UK. Comparable to AntibioEst's SPARES surveillance and stewardship mandate in scope (national antibiotic resistance data, prescriber guidance), though operating at country rather than regional scale.
• Sanford Guide (Antimicrobial Therapy, Inc.): Long-established commercial antimicrobial prescribing reference used globally by physicians, dentists, and pharmacists. Comparable to AntibioEst's prescribing guides as a competing source of antibiotic recommendations, but distributed commercially and internationally rather than as a free regional public-health service.

Direct peers

• CPias Grand Est: Centre d'Appui pour la Prévention des Infections Associées aux Soins for the Grand Est region. AntibioEst explicitly collaborates with the national CPias network and shares the same regional remit for infection prevention, making it a directly comparable coordination body within the same geography.
• CRAtb Hauts-de-France (AntibioHDF): Regional antibiotic therapy center for the neighboring Hauts-de-France region, operating under the same national decree n°2022-1445 framework as AntibioEst. Offers a directly comparable regional CRAtb model with overlapping digital tools and missions in a different French region.

Emerging players

• Firstline (clinical decision support for antimicrobial stewardship): Digital clinical decision-support platform for antimicrobial prescribing used internationally. Directly comparable to AntibioEst's Antibioguide/Antibioclic apps in functionality — mobile, guideline-based antibiotic recommendations — but operates commercially across multiple geographies and competes for prescriber mindshare.

Regional players

• OMEDIT Grand Est: Observatoire des Médicaments, des Dispositifs Médicaux et de l'Innovation Thérapeutique for Grand Est. A peer regional coordination body under ARS oversight that, like AntibioEst, disseminates therapeutic guidance and stewardship content to healthcare professionals in the same geography.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cratb-grand-est

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centre Régional en Antibiothérapie du Grand Est - AntibioEst